UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.141

Sortiert nach

Autonomic regulation of islet hormone secretion : Implications for health and disease

Diabetologia, 2000-04, Vol.43 (4), p.393-410

AHREN, B

2000

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: ameta-analysis of randomized clinical trials

Diabetes, obesity & metabolism, 2013-02, Vol.15 (2), p.112

2013

Volltextzugriff (PDF)

Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives

Diabetes & metabolism, 2013-05, Vol.39 (3), p.195-201

AHREN, B

2013

Volltextzugriff (PDF)

Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control

Diabetes & metabolism, 2015-12, Vol.41 (6), p.6S3-6S8

Ahrén, B

2015

Volltextzugriff (PDF)

GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes

Hormone and metabolic research, 2004-11, Vol.36 (11/12), p.867-876

2004

Volltextzugriff (PDF)

Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin

Diabetes, obesity & metabolism, 2011-03, Vol.13 (3), p.193-203

2011

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

Diabetes, obesity & metabolism, 2013-02, Vol.15 (2), p.112-120

2013

Volltextzugriff (PDF)

Using albumin to improve the therapeutic properties of diabetes treatments

Diabetes, obesity & metabolism, 2012-02, Vol.14 (2), p.121-129

2012

Volltextzugriff (PDF)

Methods and Models for Metabolic Assessment in Mice

Journal of diabetes research, 2013-01, Vol.2013, p.986906-8

2013

Volltextzugriff (PDF)

Islet adaptation to insulin resistance: mechanisms and implications for intervention

Diabetes, obesity & metabolism, 2005-01, Vol.7 (1), p.2-8

2005

Volltextzugriff (PDF)

Glucagon secretion in relation to insulin sensitivity in healthy subjects

Diabetologia, 2006-01, Vol.49 (1), p.117-122

AHREN, B

2006

Volltextzugriff (PDF)

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

Diabetes, obesity & metabolism, 2012-08, Vol.14 (8), p.762-767

2012

Volltextzugriff (PDF)

β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance

Diabetes (New York, N.Y.), 2009-03, Vol.58 (3), p.726-731

B. Ahrén

2009

Volltextzugriff (PDF)

Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes

Diabetologia, 2014-09, Vol.57 (9), p.1876-1883

2014

Volltextzugriff (PDF)

The future of incretin-based therapy: novel avenues-novel targets

Diabetes, obesity & metabolism, 2011-10, Vol.13 (s1), p.158-166

Ahren, B

2011

Volltextzugriff (PDF)

β-and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance : Outcome of a 12-Year Prospective Study in Postmenopausal Caucasian Women

Diabetes (New York, N.Y.), 2009-03, Vol.58 (3), p.726-731

AHREN, B

2009

Volltextzugriff (PDF)

Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice

Diabetologia, 2005-10, Vol.48 (10), p.2140-2146

2005

Volltextzugriff (PDF)

Impaired Incretin Response After a Mixed Meal Is Associated With Insulin Resistance in Nondiabetic Men

Diabetes care, 2001-09, Vol.24 (9), p.1640-1645

2001

Volltextzugriff (PDF)

CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight

Regulatory peptides, 2005-07, Vol.129 (1), p.203-211

2005

Volltextzugriff (PDF)

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Diabetes, obesity & metabolism, 2009-02, Vol.11 (2), p.157-166

2009

Volltextzugriff (PDF)

Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.775-783

2011

Volltextzugriff (PDF)

Islet nerves in focus—defining their neurobiological and clinical role

Diabetologia, 2012-12, Vol.55 (12), p.3152-3154

Ahrén, B.

2012

Volltextzugriff (PDF)

Alpha cell function in health and disease : influence of glucagon-like peptide-1

Diabetologia, 2005-09, Vol.48 (9), p.1700-1713

2005

Volltextzugriff (PDF)

Type 2 diabetes, insulin secretion and beta-cell mass

Current molecular medicine, 2005-05, Vol.5 (3), p.275

Ahrén, B

2005

Volltextzugriff (PDF)

Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes

Diabetes, obesity & metabolism, 2014-09, Vol.16 (9), p.812-818

2014

Volltextzugriff (PDF)

1 – 25 von 1.141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(931)
Mit Volltextzugriff
(803)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(714)
Life Sciences & Biomedicine
(667)
Biological And Medical Sciences
(455)
Animals
(452)
Female
(438)
Humans
(400)
Male
(331)
Endocrinology & Metabolism
(303)
Insulin Secretion
(289)
Insulin - Metabolism
(269)
Medicin Och Hälsovetenskap
(250)
Medical Sciences
(246)
Fundamental And Applied Biological Sciences. Psychology
(228)
Mice
(226)
Medical And Health Sciences
(207)
Insulin - Blood
(200)
Middle Aged
(193)
Rats
(178)
Clinical Medicine
(171)
Klinisk Medicin
(170)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autonomic regulation of islet hormone secretion : Implications for health and disease

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: ameta-analysis of randomized clinical trials

Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives

Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control

GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes

Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

Using albumin to improve the therapeutic properties of diabetes treatments

Methods and Models for Metabolic Assessment in Mice

Islet adaptation to insulin resistance: mechanisms and implications for intervention

Glucagon secretion in relation to insulin sensitivity in healthy subjects

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance

Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes

The future of incretin-based therapy: novel avenues-novel targets

β-and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance : Outcome of a 12-Year Prospective Study in Postmenopausal Caucasian Women

Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice

Impaired Incretin Response After a Mixed Meal Is Associated With Insulin Resistance in Nondiabetic Men

CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans

Islet nerves in focus—defining their neurobiological and clinical role

Alpha cell function in health and disease : influence of glucagon-like peptide-1

Type 2 diabetes, insulin secretion and beta-cell mass

Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes

Suchergebnisse filtern